CPR is a program to identify prognostic genes (biomarkers) and use them to predict prognosis of cancer patients.

Please refer to included 'manual.pdf'.

For more detail, please refer to "Improved prediction for breast cancer outcome by identifying heterogeneous biomarkers" (under review)

Latest update: 04/24/2017
